Pulmonx Corporation General and Administrative Expenses 2011-2026 | LUNG

General and Administrative Expenses — these are a part of a company's operating expenses that are not directly related to the production of goods or the provision of services but are necessary for the overall functioning of the business.

What these expenses include

Salaries of administrative staff (executives, HR, accountants, legal personnel)
Office rent and utilities
Office equipment and IT infrastructure
Professional services (auditors, lawyers, consultants)
Insurance
General administrative travel and representation expenses

What the metric indicates

Cost control
A high level of such expenses may indicate inefficient management or an overly complex structure
Profitability
Reducing administrative expenses while maintaining stable revenue increases operating profit
Comparative analysis
Investors can compare this metric as a percentage of revenue among companies in the same industry
Business flexibility
Companies with a flexible and controlled expense structure are more resilient to revenue declines

Annual General and Administrative Expenses Pulmonx Corporation

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
101 M	102 M	94.6 M	83.1 M	69.9 M	46.1 M	34.2 M	20.3 M	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
102 M	20.3 M	69 M

Quarterly General and Administrative Expenses Pulmonx Corporation

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
25.6 M	26.7 M	26.1 M	-	25.4 M	25.3 M	24.4 M	-	24 M	23.5 M	22.7 M	-	19.7 M	21.2 M	20.2 M	-	16.7 M	18.2 M	16.1 M	-	10.8 M	11.1 M	10.2 M	-	8.62 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
26.7 M	8.62 M	19.8 M

General and Administrative Expenses of other stocks in the Medical devices industry

Issuer	General and Administrative Expenses	Price	% 24h	Market Cap	Country
ClearPoint Neuro CLPT	16.5 M	$ 8.99	-4.16 %	$ 255 M	USA
EDAP TMS S.A. EDAP	5.9 M	$ 3.45	-0.29 %	$ 129 M	France
GenMark Diagnostics, Inc. GNMK	25.6 M	-	-	$ 1.77 B	USA
Acutus Medical AFIB	14.1 M	-	-26.83 %	$ 2.62 M	USA
AdaptHealth Corp. AHCO	382 M	$ 12.01	-0.5 %	$ 1.62 B	USA
Allied Healthcare Products AHPI	7.11 M	-	3.58 %	$ 2.21 M	USA
FONAR Corporation FONR	23.5 M	$ 18.6	-	$ 122 M	USA
Obalon Therapeutics, Inc. OBLN	8.78 M	-	-5.86 %	$ 30.6 M	USA
Bruker Corporation BRKR	894 M	$ 36.14	-1.65 %	$ 5.38 K	USA
Globus Medical GMED	1.18 B	$ 90.07	1.66 %	$ 12.2 B	USA
Helius Medical Technologies HSDT	9.27 M	$ 1.78	-6.32 %	$ 1.08 M	USA
Integra LifeSciences Holdings Corporation IART	717 M	$ 9.27	-0.43 %	$ 714 M	USA
Inspire Medical Systems INSP	625 M	$ 54.06	-0.15 %	$ 1.59 B	USA
Apollo Endosurgery APEN	20.6 M	-	-	$ 475 M	USA
IRIDEX Corporation IRIX	7.73 M	$ 1.01	1.34 %	$ 17.1 M	USA
Integer Holdings Corporation ITGR	212 M	$ 85.48	-0.18 %	$ 2.97 B	USA
OrthoPediatrics Corp. KIDS	120 M	$ 15.68	-1.63 %	$ 368 M	USA
LENSAR LNSR	45.2 M	$ 5.83	-1.1 %	$ 69.7 M	USA
Medtronic PLC MDT	10.8 B	$ 86.15	-0.15 %	$ 111 B	USA
CryoLife, Inc. CRY	141 M	-	-4.14 %	$ 702 M	USA
Myomo MYO	14 M	$ 0.66	-5.68 %	$ 27.6 M	USA
Avinger AVGR	14.1 M	-	-20.74 %	$ 369 K	USA
Align Technology ALGN	1.76 B	$ 166.53	-3.11 %	$ 12.5 B	USA
Orthofix Medical OFIX	554 M	$ 11.68	-0.76 %	$ 463 M	Curacao
AxoGen AXGN	44.6 M	$ 30.86	-5.45 %	$ 1.42 B	USA
Axonics Modulation Technologies AXNX	40.2 M	-	-	$ 3.31 B	USA
Aziyo Biologics AZYO	15.1 M	-	1.37 %	$ 20.5 M	USA
Penumbra PEN	663 M	$ 329.86	-	$ 12.8 B	USA
Soliton, Inc. SOLY	8.46 M	-	-1.42 %	$ 435 M	USA
Insulet Corporation PODD	1.16 B	$ 202.45	-0.52 %	$ 14.2 B	USA
Hancock Jaffe Laboratories, Inc. HJLI	4.88 K	-	-1.98 %	$ 98.3 M	USA
Itamar Medical Ltd. ITMR	8.5 M	-	0.03 %	$ 1.58 B	Israel
Misonix, Inc. MSON	18 M	-	-	$ 462 M	USA
Neovasc NVCN	14.7 M	-	-	$ 111 M	Canada
Sintx Technologies SINT	6.2 M	$ 2.53	-	$ 7.02 M	USA
Butterfly Network BFLY	39.8 M	$ 4.03	-2.54 %	$ 853 M	USA
Smith & Nephew plc SNN	2.72 B	$ 31.63	-3.06 %	$ 23.8 B	Britain
Intersect ENT, Inc. XENT	98.6 M	-	-	$ 955 M	USA
Stryker Corporation SYK	8.65 B	$ 330.34	-0.59 %	$ 126 B	USA
Cytosorbents Corporation CTSO	35.6 M	$ 0.59	0.76 %	$ 36.7 M	USA
Tactile Systems Technology TCMD	88.7 M	$ 24.31	-1.06 %	$ 556 M	USA
TELA Bio TELA	15.7 M	$ 0.67	6.38 %	$ 31.5 M	USA
TransMedics Group TMDX	185 M	$ 106.65	1.77 %	$ 3.63 B	USA
BIOLASE BIOL	10.2 M	-	-13.19 %	$ 166 K	USA
Tandem Diabetes Care TNDM	445 M	$ 19.31	0.74 %	$ 1.31 B	USA
Delcath Systems DCTH	43.5 M	$ 9.64	-0.67 %	$ 345 M	USA
BioSig Technologies BSGM	67.5 M	-	37.08 %	$ 85.7 M	USA
Boston Scientific Corporation BSX	6.89 B	$ 60.97	-2.6 %	$ 90.3 B	USA